| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-11-20 20:33 Tx date 2025-11-15 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$200,000
+25,000 vol $8.00 each |
32,678 | |
| Filed 2025-11-20 20:30 Tx date 2025-11-15 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-200,000
-25,000 vol $8.00 each |
282,500 | |
| Filed 2025-11-19 23:12 Tx date 2025-11-14 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
|
Options
99 - Correction of information
|
$200,000
+25,000 vol $8.00 each |
307,500 | |
| Filed 2025-11-07 20:46 Tx date 2025-11-02 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-200,000
-25,000 vol $8.00 each |
282,500 | |
| Filed 2025-09-24 17:10 Tx date 2025-09-24 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$16,786
+3,052 vol $5.50 each |
7,678 | |
| Filed 2025-08-11 19:31 Tx date 2025-05-13 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$237,125
+43,750 vol $5.42 each |
307,500 | |
| Filed 2025-04-14 14:09 Tx date 2025-03-31 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-350,000
-43,750 vol $8.00 each |
263,750 | |
| Filed 2025-03-27 14:10 Tx date 2025-03-25 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$231,300
+45,000 vol $5.14 each |
307,500 | |
| Filed 2024-05-22 23:33 Tx date 2024-05-13 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$178,200
+45,000 vol $3.96 each |
262,500 | |
| Filed 2024-01-12 16:35 Tx date 2024-01-12 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Pimstone, Simon Neil
4 - Director of Issuer
Holder: Dr. Simon Pimstone Inc. (Indirect Ownership)
|
Common Shares
90 - Change in the nature of ownership
|
$28,000
+4,000 vol $7.00 each |
4,000 | |
| Filed 2024-01-12 16:34 Tx date 2021-03-03 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Pimstone, Simon Neil
4 - Director of Issuer
Holder: Dr. Simon Pimstone Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-01-12 16:33 Tx date 2024-01-12 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
$-28,000
-4,000 vol $7.00 each |
4,626 | |
| Filed 2023-08-20 11:31 Tx date 2023-08-18 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$28,000
+4,000 vol $7.00 each |
8,626 | |
| Filed 2023-06-05 13:30 Tx date 2023-06-02 |
$XENE
Xenon Pharmaceuticals Inc. |
Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$719,786
+18,475 vol $38.96 each |
1,218,157 | |
| Filed 2023-06-02 18:02 Tx date 2023-06-01 |
$XENE
Xenon Pharmaceuticals Inc. |
Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-940,608.90
-24,255 vol $38.78 each |
6,000 | |
| Filed 2023-06-02 18:01 Tx date 2023-06-01 |
$XENE
Xenon Pharmaceuticals Inc. |
Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-799,304.85
-20,745 vol $38.53 each |
30,255 | |
| Filed 2023-06-02 17:59 Tx date 2023-06-01 |
$XENE
Xenon Pharmaceuticals Inc. |
Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$799,200
+45,000 vol $17.76 each |
51,000 | |
| Filed 2023-06-02 17:58 Tx date 2023-06-01 |
$XENE
Xenon Pharmaceuticals Inc. |
Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-799,200
-45,000 vol $17.76 each |
1,199,682 | |
| Filed 2023-06-02 17:56 Tx date 2023-06-01 |
$XENE
Xenon Pharmaceuticals Inc. |
Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-290,638.26
-7,458 vol $38.97 each |
6,000 | |
| Filed 2023-06-02 17:55 Tx date 2023-06-01 |
$XENE
Xenon Pharmaceuticals Inc. |
Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$-71,665.80
-1,860 vol $38.53 each |
13,458 |